公司資料
Kenvue 股價、新聞與催化劑
- 股票代碼:
- KVUE
- 交易所:
- NYSE
- 產業:
- Biopharma
- 所在地:
- United States
股票表現
17.22 USD (-2.49%)
收盤價
最後更新: 2026年10月1日
33.3B USD
市值
股價為何變動
截至 2026年10月1日，KVUE 下跌 2.49%，收於 $17.22。目前新聞監測窗口內未發現新的同公司新聞。
公司概覽
Global Consumer Health Company
Kenvue is a pure-play consumer health company with a portfolio of self-care, skin health and beauty, and essential health brands. Its products are sold through pharmacies, mass merchants, grocery stores, e-commerce channels, and other retail outlets around the world.
Self Care Portfolio
The Self Care segment includes over-the-counter products for pain, allergy, digestive health, smoking cessation, and cough, cold, and flu. Major brands include Tylenol, Zyrtec, Pepcid, and Nicorette, supported by consumer marketing and healthcare-professional recognition.
Skin Health and Beauty
Skin Health and Beauty includes brands such as Neutrogena, Aveeno, and OGX. The business competes through dermatological positioning, product renovation, digital marketing, and new formulations across facial care, sun care, body care, and hair care.
Essential Health Brands
Essential Health covers oral care, wound care, baby care, and women's health. Listerine, Band-Aid, Johnson's, Stayfree, and related brands provide recurring demand across everyday categories and give Kenvue broad retail distribution.
Brand-Led Innovation Model
Kenvue combines established household brands with formulation, packaging, and claims innovation. Recent activity includes new Neutrogena and OGX products, Listerine formats, wound-care products, and an FDA-approved fixed-dose Tylenol and naproxen combination.
未來催化劑
- U.S. retail launch of Tylenol with Naproxen following FDA approval.
近期新聞
新聞標題由機器翻譯，詳情為英文原文。
相似股票
商業成熟度、治療領域或催化劑模式相近的同業公司。